T D Gilmore

Author PubWeight™ 51.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999 4.76
2 Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 2006 3.49
3 Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 2006 3.04
4 vRel is an inactive member of the Rel family of transcriptional activating proteins. J Virol 1991 2.04
5 Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 1986 1.96
6 Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc Natl Acad Sci U S A 1998 1.81
7 Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Oncogene 1990 1.80
8 Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein pp60src. Mol Cell Biol 1982 1.49
9 The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains. Nucleic Acids Res 1992 1.36
10 LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim Biophys Acta 2001 1.33
11 A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol 1991 1.29
12 Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J Biol Chem 1997 1.25
13 Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene 1999 1.24
14 p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol 1992 1.24
15 Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J Virol 1994 1.12
16 v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene 1993 1.07
17 The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells. Oncogene 1995 1.06
18 Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Oncogene 1993 1.03
19 Characterization of mouse Trip6: a putative intracellular signaling protein. Gene 1999 0.99
20 Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site. Oncogene 1991 0.99
21 Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity. Oncogene 2006 0.97
22 Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile. Oncogene 2009 0.97
23 The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts. Oncogene 1993 0.96
24 Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene 1996 0.94
25 AAT1, a gene encoding a mitochondrial aspartate aminotransferase in Saccharomyces cerevisiae. Biochim Biophys Acta 1992 0.92
26 LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor. Gene Expr 1999 0.92
27 NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol 1993 0.92
28 Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae. Cell Growth Differ 1995 0.91
29 The spleen necrosis virus int gene product expressed in Escherichia coli has DNA binding activity and mediates att and U5-specific DNA multimer formation in vitro. Virology 1987 0.91
30 Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Oncogene 2008 0.90
31 A conditional mutant of vRel containing sequences from the human estrogen receptor. Virology 1993 0.88
32 Temperature-sensitive transforming mutants of the v-rel oncogene. J Virol 1993 0.86
33 Total synthesis of the NF-kappa B inhibitor (-)-cycloepoxydon: utilization of tartrate-mediated nucleophilic epoxidation. J Am Chem Soc 2001 0.85
34 Characterization of a chicken cDNA encoding the retinoblastoma gene product. Biochim Biophys Acta 1994 0.84
35 GAL4-I kappa B alpha and GAL4-I kappa B gamma activate transcription by different mechanisms. Nucleic Acids Res 1993 0.83
36 Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein. Oncogene 2000 0.82
37 Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3. Biochim Biophys Acta 2001 0.80
38 Clinically relevant findings. J Clin Invest 1997 0.78
39 Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo. Mol Cell Biol 1996 0.78
40 Transcription factors, oncogenes, and apoptosis. Science 1997 0.76
41 Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells. Oncogene 2000 0.76
42 The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB. Mol Cell Biol Res Commun 2001 0.75
43 Aseismic uplift in california. Science 1981 0.75
44 In vitro-translated diphtheria toxin A chain inhibits translation in wheat germ extracts: analysis of biologically active, caspase-3-resistant diphtheria toxin mutants. Biochim Biophys Acta 1999 0.75
45 Classroom performance and voice characteristics as measured by the contour sound spectrogram: preliminary report. Psychol Rep 1970 0.75